E394K
Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource cardInteractive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Ionic bond | R375 | — | Lost |
| Ionic bond | R522 | — | Lost |
| Hydrogen bond | R375 | — | Lost |
| Hydrogen bond | V390 | V390 | Preserved |
| Hydrogen bond | E391 | — | Lost |
| Hydrogen bond | F397 | F397 | Preserved |
| Hydrogen bond | G398 | G398 | Preserved |
| Hydrogen bond | R522 | — | Lost |
| Polar contact | R375 | — | Lost |
| Polar contact | V390 | V390 | Preserved |
| Polar contact | E391 | E391 | Preserved |
| Polar contact | F397 | — | Lost |
| Polar contact | G398 | G398 | Preserved |
| Polar contact | R522 | — | Lost |
| Van der Waals | W371 | — | Lost |
| Van der Waals | — | R522 | Gained |
| Hydrophobic | W371 | W371 | Preserved |
| Hydrophobic | F374 | F374 | Preserved |
| Hydrophobic | V390 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Full Variant Card
WFS1 Wolframin — E394K Variant Card
Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill
Glutamic acid → Lysine at position 394. Cytoplasmic loop 2. ClinVar Uncertain significance, AlphaMissense 0.742, DynaMut2 ΔΔG -0.07 kcal/mol (destabilising).
Identity
| Field | Value |
|---|---|
| Variant | E394K (p.Glutamic acid394Lysine) |
| DNA change | c.1180G>A |
| Gene · Protein | WFS1 · Wolframin (890 aa) |
| UniProt | O76024 · WFS1_HUMAN |
| ClinVar accession | VCV000904869 |
| Amino acid change | Glutamic acid (E) → Lysine (K) |
Structural Context
| Field | Value |
|---|---|
| AlphaFold model | AF-O76024-F1, v6 |
| pLDDT at residue 394 | 82.06 — well-folded |
| Domain | Cytoplasmic loop 2 |
| Position context | Loop region · position 394 sits between transmembrane segments, solvent-accessible |
| IDR flag | No — pLDDT above 50 threshold |
UniProt features at this position:
(none catalogued)
Position 394 sits in a connecting loop between transmembrane helices. Loop residues are typically solvent-exposed and often contribute to interhelical contacts or serve as recognition sites for binding partners. The wild-type residue is negatively charged (glutamate — carboxylate); the mutant is positively charged (lysine — primary amine). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.
Computational Predictions
AlphaMissense
| Field | Value |
|---|---|
| am_pathogenicity | 0.7422 |
| am_class | likely pathogenic |
| Interpretation | Likely pathogenic (threshold 0.564) |
DynaMut2
| Field | Value |
|---|---|
| ΔΔG (kcal/mol) | -0.07 (Destabilising) |
| Job ID | 178092121707 |
| Result URL | https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092121707 |
Clinical Evidence
| Field | Value |
|---|---|
| Classification | Uncertain significance |
| Review status | criteria provided, multiple submitters, no conflicts |
| Last evaluated | 2024/03/11 00:00 |
| Inheritance | Autosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6). |
| WFS1 variant landscape | E394K is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar) |
- Autosomal dominant nonsyndromic hearing loss 6
- WFS1-Related Spectrum Disorders
- Cataract 41
- Wolfram syndrome 1
- Type 2 diabetes mellitus
- Wolfram-like syndrome
Research Path Decision Tree
ΔΔG < 2 + binding site affected → CATEGORY 3 — docking experiments
ΔΔG 2–4 → CATEGORY 2 — pharmacological chaperones
ΔΔG > 4 → CATEGORY 1 — gene therapy
pLDDT < 50 → CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit → CATEGORY 4 — site-specific docking
Final Schema Categorization
Category 3/4 — Most Druggable
<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.07 < 2 kcal/mol (fold intact) + AlphaMissense 0.742 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.
Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.07 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.742. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.
Files in this folder
AF-O76024-F1-model_v6.pdb— AlphaFold structureE394K_molstar_viewer.html— interactive 3D viewer (auto-highlights position 394 with ball-and-stick + neighbors within 5Å)E394K_variant_card.md— this card (source of truth)E394K_variant_card.html— styled printable cardE394K_dynamut2_summary.html— clean offline DynaMut2 result carddynamut2_result.json— structured result datadynamut2_result_page.html— local snapshot of the Biosig result page (asset URLs absolutized)E394K_wildtype_interactions.pse/E394K_mutant_interactions.pse— PyMOL sessions
Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.
Feed this card to Wolfram Intelligence
Download the E394K PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.